SNV4818 in Participants With Advanced Solid Tumors

计划入组 320 人 · 首次发布于 2024 年 12 月 17 日

SNV1521 in Participants With Advanced Solid Tumors

计划入组 400 人 · 首次发布于 2024 年 1 月 24 日

First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer

计划入组 40 人 · 首次发布于 2026 年 8 月 10 日

SNV-4818

SNV-0

SNV-1521

RNV LLC

United States

SLV Pharmaceuticals LLC

United States

Galderma Research & Development SNC

France

SJPedPanel: A Targeted Gene Panel for Enhanced Detection of Driver Alterations in Childhood Cancers

Calidi Biotherapeutics' RTNova Platform Shows Promise in Targeting Metastatic Cancers

STREAM Program Delivers Actionable Genomic Insights for 59% of Pediatric Cancer Patients in Asia's First Nationwide WGS Initiative